C12Y 401/01017
Ornithine decarboxylase
Official title: Ornithine decarboxylase (4.1.1.17)
C12Y401/01017 (Ornithine decarboxylase) appears on 23 US grants and 37 published applications in this corpus.
Search patents in C12Y- Granted patents
- 23
- Published applications
- 37
- Assignees
- 21
- Inventors
- 83
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 2 | 3 |
| 2017 | 1 | 2 |
| 2018 | 2 | 4 |
| 2019 | 1 | 2 |
| 2020 | 5 | 6 |
| 2021 | 3 | 1 |
| 2022 | 4 | 2 |
| 2023 | 0 | 2 |
| 2024 | 1 | 3 |
| 2025 | 2 | 1 |
| 2026 | 0 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Tropane alkaloid (TA) producing non-plant host cells, and methods of making and using the same25 Nov 2025US 12,480,131 B2The Board of Trustees of the Leland Stanford Junior University
- Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system26 Aug 2025US 12,397,022 B2Holobiome, Inc.
- Ornithine decarboxylase variant and method for producing putrescine by using same12 Nov 2024US 12,139,733 B2Cj Cheiljedang Corporation
- Modified polypeptide having an activity of ornithine-based product exporter and method for producing ornithine-based product using cells expressing the polypeptide8 Nov 2022US 11,492,648 B2Cj Cheiljedang Corporation
- Microorganism for producing ornithine and process for producing ornithine using them21 Jun 2022US 11,365,400 B2Cj Cheiljedang Corporation
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Enzyme co-immobilization for biosynthesis20 Aug 2026US 2026/0242427 A1The Chinese University of Hong Kong
- Polyethylenimine-modified cry proteins and their use20 Aug 2026US 2026/0242428 A1The Chinese University of Hong Kong
- Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system1 Jan 2026US 2026/0000717 A1Holobiome, Inc.
- Novel GLV-Phenolamide: Biosynthesis and Function in Protecting Plants from Herbivore Attack13 Feb 2025US 2025/0051266 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
Most cited
By later US patents
- Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system7US 11,116,804 B2Holobiome, Inc. · 2021
- Method for increasing plant yield by expressing a nucleic acid encoding an ornithine decarboxylase polypeptide and plants expressing the same3US 9,234,205 B2BASF Plant Science GmbH · 2016
- Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof2US 7,504,253 B2Burnham Institute for Medical Research · 2009
- Microorganisms for producing putrescine and process for producing putrescine using them1US 9,657,264 B2Cj Cheiljedang Corporation · 2017